Evidence map›Paper›PMID 20458382›Full record

ArticleMolecular bioSystems2010

Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context.

Elizabeth J Joslin, Harish Shankaran, Lee K Opresko, Nikki Bollinger, Douglas A Lauffenburger, H Steven Wiley

Open access · greenAbstract read
In one paragraph

Article in Molecular bioSystems, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dynamics and Sensitivity of Signaling Pathways.Current pathobiology reports · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elizabeth J JoslinDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Harish Shankaran
Lee K Opresko
Nikki Bollinger
Douglas A Lauffenburger
H Steven Wiley
Pacific Northwest National Laboratory · USMassachusetts Institute of Technology · US

Funding

Engineered Antibody EGFR Antagonist Cancer TherapeuticsR01CA096504 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WITTRUP, KARL DANE · 2002 to 2017
$9.7M
NCI NIH HHS CA96504NCI NIH HHS R01 CA096504
6 · The paper itself

Abstract

Transactivation of the epidermal growth factor receptor (EGFR) is thought to be a process by which a variety of cellular inputs can be integrated into a single signaling pathway through either stimulated proteolysis (shedding) of membrane-anchored EGFR ligands or by modification of the activity of the EGFR. As a first step towards building a predictive model of the EGFR transactivation circuit, we quantitatively defined how signals from multiple agonists were integrated both upstream and downstream of the EGFR to regulate extracellular signal regulated kinase (ERK) activity in human mammary epithelial cells. By using a "non-binding" reporter of ligand shedding, we found that transactivation triggers a positive feedback loop from ERK back to the EGFR such that ligand shedding drives EGFR-stimulated ERK that in turn drives further ligand shedding. Importantly, activated Ras and ERK levels were nearly linear functions of ligand shedding and the effect of multiple, sub-saturating inputs was additive. Simulations showed that ERK-mediated feedback through ligand shedding resulted in a stable steady-state level of activated ERK, but also showed that the extracellular environment can modulate the level of feedback. Our results suggest that the transactivation circuit acts as a context-dependent integrator and amplifier of multiple extracellular signals and that signal integration can effectively occur at multiple points in the EGFR pathway.

Indexed as

Cell LineDose-Response Relationship, DrugEpithelial CellsErbB ReceptorsExtracellular Signal-Regulated MAP KinasesFlavonoidsGefitinibGene Regulatory NetworksHepatocyte Growth FactorHumansImidazolesLigandsLysophospholipidsMammary Glands, HumanPhosphorylationPyridines2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneErbB ReceptorsExtracellular Signal-Regulated MAP KinasesFlavonoidsGefitinibHepatocyte Growth FactorImidazolesLigandslysophosphatidic acidLysophospholipidsPyridinesQuinazolinesSB 203580Transforming Growth Factor alpha

Identifiers

PMID20458382
PMCPMC3306786
OpenAlexW1985903986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.